Hangzhou Biotest Biotech Co Ltd
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immun… Read more
Hangzhou Biotest Biotech Co Ltd (688767) - Total Liabilities
Latest total liabilities as of September 2025: CN¥134.75 Million CNY
Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has total liabilities worth CN¥134.75 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hangzhou Biotest Biotech Co Ltd - Total Liabilities Trend (2017–2024)
This chart illustrates how Hangzhou Biotest Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hangzhou Biotest Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
|
China | CN¥169.78 Million |
|
Integrated Service Technology
TWO:3289
|
Taiwan | NT$5.47 Billion |
|
Hengdian Entertainment Co Ltd Class A
SHG:603103
|
China | CN¥2.51 Billion |
|
RMR Group Inc
NASDAQ:RMR
|
USA | $272.28 Million |
|
Guangzhou Jinzhong Auto Parts Manufacturing Co. Ltd.
SHE:301133
|
China | CN¥1.16 Billion |
|
Yonker Environmental Protect
SHE:300187
|
China | CN¥2.42 Billion |
|
Zhejiang Hongchang Electrical Technology Co. Ltd.
SHE:301008
|
China | CN¥694.38 Million |
|
Sichuan Haowu Electromechanical Co Ltd
SHE:000757
|
China | CN¥869.15 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Hangzhou Biotest Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hangzhou Biotest Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hangzhou Biotest Biotech Co Ltd (2017–2024)
The table below shows the annual total liabilities of Hangzhou Biotest Biotech Co Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥189.79 Million | +19.50% |
| 2023-12-31 | CN¥158.82 Million | -15.93% |
| 2022-12-31 | CN¥188.92 Million | -41.58% |
| 2021-12-31 | CN¥323.36 Million | +69.39% |
| 2020-12-31 | CN¥190.89 Million | +125.92% |
| 2019-12-31 | CN¥84.50 Million | +49.60% |
| 2018-12-31 | CN¥56.48 Million | +17.96% |
| 2017-12-31 | CN¥47.88 Million | -- |